This data supports the concept that CTGF may have a role in ulcer healing in diabetes, and combined with the rodent data described in this paper and our previous data in a primate non-human (baboon) model of diabetic wounding [18], it provides greater rationale for studying CTGF as therapy in diabetic foot ulcers. This evidence concerns the gene CCN2 and diabetic foot.